Scott T. Garrett's Insider Trades & SAST Disclosures
Scott T. Garrett's most recent trade in HCW Biologics Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Scott T. Garrett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCW Biologics Inc | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Sale of securities on an exchange or to another person at price $ 75.50 per share. | 14 Mar 2024 | 16,441 | 48,611 (0%) | 0% | 75.5 | 1,241,296 | Common Stock |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. | 14 Mar 2024 | 9,039 | 57,650 (0%) | 0% | 26.7 | 241,703 | Common Stock |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 9,039 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 7,402 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.04 per share. | 14 Mar 2024 | 7,402 | 65,052 (0%) | 0% | 36.0 | 266,768 | Common Stock |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 48,611 (0%) | 0% | - | Common Stock | |
| HCW Biologics Inc | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 20 Feb 2024 | 142,858 | 267,858 | - | 1.4 | 200,001 | Common Stock |
| Hologic, Inc. | Garrett T. Scott | Director | Sale of securities on an exchange or to another person at price $ 68.71 per share. | 11 Dec 2023 | 10,000 | 47,039 (0%) | 0% | 68.7 | 687,116 | Common Stock |
| Hologic, Inc. | Scott T. Garrett | Director | Sale of securities on an exchange or to another person at price $ 79.72 per share. | 15 Jun 2023 | 10,000 | 57,039 (0%) | 0% | 79.7 | 797,240 | Common Stock |
| HCW Biologics Inc | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 67,039 (0%) | 0% | - | Common Stock | |
| HCW Biologics Inc | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 41,841 | 41,841 | - | - | Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 65,574 (0%) | 0% | - | Common Stock | |
| HCW Biologics Inc | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 20,964 | 20,964 | - | - | Stock Option | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 64,009 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. | 09 Nov 2020 | 11,146 | 62,531 (0%) | 0% | 22.3 | 249,113 | Common Stock |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 11,146 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2020 | 24,204 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Scott T. Garrett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.34 per share. | 01 May 2020 | 24,204 | 51,385 (0%) | 0% | 20.3 | 492,309 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges